Arkuda Therapeutics scores $44 mln Series A
Cambridge, Massachusetts-based Arkuda Therapeutics, a biotech firm, has raised $44 million in Series A financing. Atlas Venture and Pfizer Ventures led the round with participation from funds managed by Tekla Capital Management LLC and BioInnovation Capital.
8 November 2019•1 min read
